Enveric Biosciences Inc (ENVB)

Enveric Biosciences, Inc. (ENVB) is a patient-first biotechnology company with a mission to revolutionize the standard approaches to health and wellness, particularly in the area of mental health, oncology supportive care, and neurology. The company is developing novel cannabinoids as well as innovative products to improve quality of life for cancer patients and other patients experiencing distressing side effects from conventional treatments.

Enveric Biosciences operates with a strong focus on the Science of Healing, combining advanced research in the fascinating field of cannabinoids with clinical applications aimed at providing supportive care and improving patients' lives. The company's approach of bringing together benchtop research and clinical practice is spearheaded by a team of experts experienced in the discovery and clinical development of chemical entities, natural health products, and medical devices.

The company's research is currently focused around cannabinoids—chemical compounds found in cannabis plants—with specific emphasis on treating side effects experienced by cancer patients, such as chemo-induced peripheral neuropathy, radiodermatitis, and chemotherapy-induced nausea and vomiting.

With a commitment to rigorous scientific methodology, clinical research, and patient-centered care, Enveric Biosciences follows all processes required to become an FDA-approved company. The aim is to not only alleviate the distressing side effects experienced by patients undergoing medical treatments but also to meaningfully improve patients' overall quality of life.

Enveric Biosciences operates from its headquarters in Florida and is listed on the Nasdaq Capital Market under the symbol "ENVB." As a publicly traded company, Enveric Biosciences positions its stakeholders at the core of its business strategy, prioritizing honesty and transparency in all its business dealings. The company disseminates frequent updates about its research processes, products under development, and other aspects of its operations to its investors, so they have clear, comprehensive, and up-to-date knowledge of its activities.

Enveric Biosciences believes in the therapeutic potential of cannabinoids and aims to push the envelope in capturing this potential for the benefit of patients worldwide. It is continuously on the lookout for innovative solutions in bio-health, and through rigorous clinical testing and research, it is committed to offering groundbreaking treatments that bring about a profound change in healthcare.